Jan Skvarka is the founder of Trillium Therapeutics. Trillium Therapeutics has raised $300M in total funding. Latest round: Growth. Backed by Pfizer.
Jan Skvarka served as President and Chief Executive Officer of Trillium Therapeutics, a clinical-stage immuno-oncology company. He led the company through a turnaround, raising $300 million across two funding rounds, which culminated in its acquisition by Pfizer for $2.26 billion in 2023.
Full founder directory · Investor directory · Company funding database · Fundraising library